| Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017) (NCT05227118) | Merck Sharp & Dohme LLC | 2022-07-01 |
| A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension (NCT04187547) | Cerecin | 2022-06-30 |
| A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease (NCT05310071) | Biogen | 2022-06-02 |
| Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease (NCT05423522) | Medesis Pharma SA | 2022-05-20 |
| Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases (NCT06731842) | Karolinska Institutet | 2022-05-15 |
| Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease (NCT05267535) | Neurim Pharmaceuticals Ltd. | 2022-05-12 |
| Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease (NCT05352763) | Cassava Sciences, Inc. | 2022-05-12 |
| Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects (NCT05363293) | Alzamend Neuro, Inc. | 2022-05-04 |
| Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease (NCT05176704) | Innodem Neurosciences | 2022-04-15 |
| "Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program" (NCT05350410) | Alzheimer's Disease Cooperative Study (ADCS) | 2022-04-05 |
| Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects (NCT04141150) | APRINOIA Therapeutics, LLC | 2022-03-22 |
| Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection. (NCT05978830) | First Affiliated Hospital of Zhejiang University | 2022-03-01 |
| A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment (NCT05040217) | Mark Tuszynski | 2022-02-07 |
| Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures (NCT05153941) | Altoida | 2022-01-31 |
| [18F]APN-1607 PET in Subjects With AD Compared to HC (NCT05542953) | APRINOIA Therapeutics | 2022-01-21 |
| Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia (NCT05519137) | Icahn School of Medicine at Mount Sinai | 2022-01-06 |
| Association of Cognition With Functional Mobility in People With Alzheimer's Disease (NCT05113732) | Istanbul University - Cerrahpasa | 2021-11-01 |
| Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use (NCT04820127) | University Hospital, Toulouse | 2021-10-14 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease (NCT05074498) | TrueBinding, Inc. | 2021-10-08 |
| PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease (NCT04396873) | National Institute of Mental Health (NIMH) | 2021-08-17 |
| Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM® (NCT04954534) | Samsung Medical Center | 2021-07-12 |
| Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease (NCT04926272) | First Affiliated Hospital of Fujian Medical University | 2021-07-01 |
| The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment (NCT04073628) | Icahn School of Medicine at Mount Sinai | 2021-06-14 |
| A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) (NCT04867616) | UCB Biopharma SRL | 2021-06-09 |
| A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects (NCT04973189) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-05-08 |
| Autobiographical Memory (NCT04584138) | Nantes University Hospital | 2021-04-15 |
| Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) (NCT04730635) | Merck Sharp & Dohme LLC | 2021-03-23 |
| MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005) (NCT04308304) | Merck Sharp & Dohme LLC | 2021-02-16 |
| Self-Management Intervention: Considering Needs & Preferences of Dementia Caregivers (Caregiver Career Study) (NCT04603482) | Case Western Reserve University | 2021-01-08 |
| New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study (NCT04426539) | American College of Radiology | 2020-12-17 |
| A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants (NCT04476303) | BeyondBio Inc. | 2020-08-27 |
| Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis (NCT04850053) | Capital Medical University | 2020-08-26 |
| A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 (NCT04241068) | Biogen | 2020-03-02 |
| Induction and Recognition of Emotions (NCT04353947) | University of Valencia | 2020-03-02 |
| A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease (NCT04137926) | Shanghai Mental Health Center | 2020-03-01 |
| A Noval Tau Tracer in Young Onset Dementia (NCT04248270) | Chang Gung Memorial Hospital | 2020-02-20 |
| Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination (NCT04305210) | Chang Gung Memorial Hospital | 2019-12-01 |
| Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease (NCT02359864) | Corewell Health East | 2019-10-01 |
| Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) (NCT03740178) | Merck Sharp & Dohme LLC | 2019-09-27 |
| Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) (NCT04666077) | Icahn School of Medicine at Mount Sinai | 2019-08-27 |
| Efficacy of Hypnosis on Pain and Anxiety During Lumbar Puncture for Etiological Diagnosis of Cognitive Impairment (NCT04368572) | Gérond'if | 2019-08-01 |
| The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. (NCT03945968) | Russian Federation of Anesthesiologists and Reanimatologists | 2019-07-01 |
| Effect of REST in the Alzheimer Disease Continuum (NCT03884023) | Dongzhimen Hospital, Beijing | 2019-06-28 |
| A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects (NCT03935568) | Samus Therapeutics, Inc. | 2019-06-24 |
| Brain Sleep Deprivation MRI Effects (BEDTIME) (NCT02741505) | NYU Langone Health | 2019-06-01 |
| Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects (NCT03817684) | Tetra Discovery Partners | 2019-04-30 |
| Trial of Rifaximin in Probable Alzheimer's Disease (NCT03856359) | Duke University | 2019-04-09 |
| Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects (NCT04169126) | Chang Gung Memorial Hospital | 2019-04-01 |
| Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease (NCT04174287) | Chang Gung Memorial Hospital | 2019-03-28 |
| An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) (NCT03712787) | AbbVie | 2019-03-22 |
| Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration (NCT05787028) | South China Center For Innovative Pharmaceuticals | 2019-01-30 |
| A Study of Semorinemab in Patients With Moderate Alzheimer's Disease (NCT03828747) | Genentech, Inc. | 2019-01-25 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 (NCT03838185) | Abrexa Pharmaceuticals, Inc. | 2019-01-22 |
| Evaluating the Effectiveness of a New Way of Organizing Primary Health Care to Improve the Management of Alzheimer's Disease (NCT03360552) | Assistance Publique Hopitaux De Marseille | 2019-01-16 |
| A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type. (NCT02989402) | Novartis Pharmaceuticals | 2018-12-31 |
| A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities (NCT03639987) | Biogen | 2018-12-20 |
| Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease (NCT03790982) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2018-12-01 |
| Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia (NCT03672201) | Centre for Addiction and Mental Health | 2018-11-01 |
| Prazosin for Agitation in Alzheimer's Disease (NCT03710642) | Alzheimer's Disease Cooperative Study (ADCS) | 2018-10-23 |
| A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type (NCT03594123) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-10-11 |
| A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease (NCT03316898) | Allergan | 2018-09-30 |
| Effects of Group Music Therapy Interventions on Alzheimer's Disease Patients: a Three-arm Randomized Controlled Blind Study. (NCT04761497) | Universidad Católica San Antonio de Murcia | 2018-09-12 |
| The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease (NCT05020106) | Capital Medical University | 2018-09-01 |
| Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease (NCT03019757) | Douglas Scharre | 2018-08-30 |
| An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311 (NCT03531710) | United Neuroscience Ltd. | 2018-08-10 |
| Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) (NCT02033941) | Hillel Grossman | 2018-07-03 |
| A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD) (NCT03668405) | H. Lundbeck A/S | 2018-06-26 |
| Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease (NCT03352557) | Biogen | 2018-05-03 |
| Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training (NCT03503669) | University of California, Los Angeles | 2018-05-01 |
| Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia (NCT03441516) | Yuhan Corporation | 2018-04-19 |
| An Open-Label Crenezumab Study in Participants With Alzheimer's Disease (NCT03491150) | Hoffmann-La Roche | 2018-04-11 |
| An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease (NCT02537626) | Erchonia Corporation | 2018-03-15 |
| A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS) (NCT03438604) | Corium, Inc. | 2018-02-13 |
| A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations (NCT03432195) | Corium, Inc. | 2018-01-31 |
| 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls (NCT03625128) | Chang Gung Memorial Hospital | 2018-01-02 |
| Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care (NCT03456349) | Nxera Pharma UK Limited | 2017-11-10 |
| A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept® (NCT03259958) | Corium, Inc. | 2017-10-30 |
| Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease (NCT02672306) | South China Research Center for Stem Cell and Regenerative Medicine | 2017-10-20 |
| A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease (NCT03289143) | Genentech, Inc. | 2017-10-04 |
| Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers (NCT02130661) | GlaxoSmithKline | 2017-10-01 |
| Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease (NCT03307993) | H. Lundbeck A/S | 2017-09-22 |
| Tango for Alzheimer's Disease Patients' Caregivers (NCT03269149) | Emory University | 2017-09-19 |
| Genistein as a Possible Treatment for Alzheimer's Disease. (NCT01982578) | Fundación para la Investigación del Hospital Clínico de Valencia | 2017-09-01 |
| MR Guided tDCS in Alzheimer's Disease (NCT03325205) | University of Tromso | 2017-08-22 |
| Retinal Imaging in Neurodegenerative Disease (NCT03233646) | Duke University | 2017-07-20 |
| Nicotinamide as an Early Alzheimer's Disease Treatment (NCT03061474) | University of California, Irvine | 2017-07-12 |
| Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid (NCT02719327) | VA Office of Research and Development | 2017-06-08 |
| Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial. (NCT03172117) | Medipost Co Ltd. | 2017-05-19 |
| Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease (NCT02941289) | Centre Hospitalier Universitaire de Nice | 2017-04-27 |
| The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression (NCT02849639) | Daniela Moga | 2017-04-04 |
| Auditory Rehabilitation and Cognition in Alzheimer Patients (NCT03002142) | University Hospital, Tours | 2017-03-31 |
| A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) (NCT03114657) | Hoffmann-La Roche | 2017-03-29 |
| A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia (NCT02972658) | AstraZeneca | 2017-03-15 |
| Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease (NCT02925650) | Annovis Bio Inc. | 2017-03-02 |
| Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants (NCT02685969) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2017-03-01 |
| Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (NCT02792257) | Johns Hopkins University | 2017-03-01 |
| Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease (NCT03056729) | Biogen | 2017-02-17 |
| The Locus Coeruleus and Memory (NCT02363504) | Maastricht University Medical Center | 2017-02-01 |
| BAC in Patient With Alzheimer's Disease or Vascular Dementia (NCT02467413) | Botanicure Co., Ltd. | 2017-01-30 |
| A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease (NCT02880956) | AbbVie | 2017-01-26 |